A drug‐repositioning screen for primary pancreatic ductal adenocarcinoma cells identifies 6‐thioguanine as an effective therapeutic agent for TPMT‐low cancer cellsInki Kim, Suhwan Chang, Je‐Keun Rhee et al.|Molecular Oncology|2018Cited by 35
Antibody-mediated blockade for galectin-3 binding protein in tumor secretome abrogates PDAC metastasisYeon‐Sook Choi, Suhwan Chang, Myung Ji Kim et al.|Proceedings of the National Academy of Sciences|2022Cited by 23
A pharmacogenomic analysis using L1000CDS2 identifies BX-795 as a potential anticancer drug for primary pancreatic ductal adenocarcinoma cellsEun A Choi, Suhwan Chang, Song Cheol Kim et al.|Cancer Letters|2019Cited by 18